Every one of those 1 sits in a single category, market-trends. Apollo Hospitals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Lysin therapy, all published on July 23, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Lysin therapy
Every one of those 1 sits in a single category, market-trends. Apollo Hospitals is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Lysin therapy, all published on July 23, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Lysin therapy. Shared-story counts are live from our verified record — not editorial picks.
Apollo Hospitals partners with Precisio Biotix to introduce next-generation lysin therapies in India, directly addressing the country's 297,000 annual deaths from antimicrobial resistance. The collaboration will leverage Apollo's vast hospital network for clinical validation and compassionate use programs, potentially transforming hospital infection control and patient outcomes.
